Victor M. Montori, MD, MSc
Montori VM. Vildagliptin was noninferior to rosiglitazone for glycemic control in type 2 diabetes but caused less weight gain. ACP J Club. 2007;146:74. doi: 10.7326/ACPJC-2007-146-3-074
Download citation file:
Published: ACP J Club 2007;146(3):74.
Learn more about subscription options.
Register Now for a free account.
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only